Theoretical model for bone graft success.
Theoretical assumptions must correlate with clinical efficacy and good surgical outcomes to be of value to clinicians and patients. This article examines several common assumptions regarding the use of bone marrow aspirate to enhance bone grafting procedures. Contrary to these assumptions, evidence-based research suggests the following: (1) No more than 4 mL of bone marrow should be aspirated from a single donor site. Aspiration of more than that amount does not substantially increase the number of progenitor cells harvested but instead dilutes the concentration of progenitor cells with other nucleated cells from peripheral blood. (2) Bone marrow aspirate should not be concentrated using centrifuge technology. Rather than isolating desired cells, centrifuging concentrates all nucleated cells, increasing the overall metabolic activity to the detriment of the desired cells. (3) Increasing the volume of graft material brought to a graft site has the unwanted effect of increasing the diffusion distance for oxygen and nutrients and may lead to graft necrosis. (4) Histomorphometric analysis is the most effective method of evaluating bone graft outcomes because only such analysis allows for quantification of the percentage of bone and viable cells within a bone core biopsy.
soltandds@aol.com
Muna
M
Soltan
Dennis G
DG
Smiler
Christie
C
Soltan
Hari S
HS
Prasad
Michael D
MD
Rohrer
D062005:Biopsy, Large-Core Needle; D001773:Blood Cells / Q000166:cytology; D001854:Bone Marrow Cells / Q000166:cytology; D016025:Bone Transplantation / Q000379:methods*; D002452:Cell Count; D002470:Cell Survival / Q000502:physiology; D002498:Centrifugation; D000075202:Contraindications; D003584:Cytological Techniques; D019317:Evidence-Based Medicine; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D008954:Models, Biological; D010101:Oxygen Consumption / Q000502:physiology; D020858:Tissue and Organ Harvesting / Q000379:methods; D060053:Transplant Donor Site; D016896:Treatment Outcome